MeSH tree: E02.815.160
Cancer survivors significantly improved their strength and immune health after completing a 10-week resistance training program as part of a pilot study led by Shernan Holtan, MD, Chief of Blood and Marrow Transplantation ...
Jun 8, 2026
0
7
As tumors outgrow their blood and nutrient supplies, or respond to treatments like chemotherapy and radiotherapy, individual cancer cells die, exposing their internal scaffolds. These dead cells are an abundant source of ...
May 20, 2026
0
8
Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University ...
Apr 15, 2026
0
2
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, ...
Mar 12, 2026
0
9
Edward (Ed) Waldner had no idea why he didn't feel well, but he knew he didn't feel like himself. At 55 years of age, he felt exhausted all the time. It didn't seem to matter how hard he had worked that day. He wondered if ...
Feb 10, 2026
0
55
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about sustainability, prevention ...
Jan 12, 2026
0
17
Treating patients who have stage III non-small cell lung cancer (NSCLC) with durvalumab concurrent with chemoradiotherapy (CRT) and continuing as consolidation therapy did not improve overall survival compared to consolidation ...
Sep 8, 2025
0
11
The mystery of how cancers build up resistance mechanisms and evade the treatments that should have destroyed them is a hugely pressing question. Overcoming cancer treatment resistance—a phenomenon that contributes to as ...
Jul 17, 2025
0
26
Patients and clinicians have welcomed the results of the ACT4 PLATO trial, which was the first clinical trial in the world to randomly assign patients with anal cancer to receive different doses of radiotherapy.
May 15, 2025
0
12
Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer patients. By combining tumor marker readings with patients' genetic information, their model predicts ...
Apr 29, 2025
0
18
